The Summer issue of Drug Discovery World (DDW) is out now! The DDW Summer issue is out now and looks at where the global biotech hubs are for drug discovery and development, asks how 3D genomics can accelerate personalised medicine, and looks at the technological advances in mass spectrometry. It also includes an exclusive global cancer research guide examining the innovation happening in this sector. Other features in the Summer issue include: - How AI can advance the hit-to-lead process - GSK’s efforts in the autoimmune sector - Improving viral vector safety for cell & gene therapy Read the digital version here: https://lnkd.in/eEiBFnsz #DrugDiscovery #DrugDevelopment #LifeSciences
Drug Discovery World
Book and Periodical Publishing
The Global Business Review of Drug Discovery and Development
About us
Welcome to our LinkedIn page. This is where we will share original content from the DDW team and industry experts, as well as daily news and other company updates. Published for over 20 years, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry Gurus’ to discuss and encourage debate on some of the more challenging issues surrounding the technological, strategic and business facets of the pharma and biopharmaceutical industry. DDW has always adhered to the maxim….’Turning Science into Business’. DDW examines the advances in new science and technology with a view to the commercial implications of implementing those advances and whether they can truly bring benefits to the drug discovery and development process with the goal of reducing costs and attrition rates whilst ultimately, bringing new and effective therapeutics to the market faster. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level allowing them to understand the new technologies and strategies and the impact they can have on their particular segments of the business. Scientist and CEO alike can profit from the uncomplicated style of the editorial and, furthermore, gain a wealth of information on a diverse range of life science topics. In our articles, we challenge the industry to look at new ways of overcoming discovery bottlenecks, embrace new technologies, form relationships with discovery partners and build next generation technology platforms.
- Website
-
https://www.ddw-online.com/
External link for Drug Discovery World
- Industry
- Book and Periodical Publishing
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Drug Discovery, Pharmaceuticals, Publishing, Biotechnology, and Biopharmaceutical
Locations
-
Primary
London, GB
Employees at Drug Discovery World
Updates
-
Discover the benefits of a bespoke biosafety cabinet A new on-demand webinar is now available to watch for free, entitled ‘Customising biosafety cabinets: A holistic approach‘. Watch this on-demand webinar from Nuaire to learn more about: - Situations that may require a bespoke biosafety cabinet (BSC) instead of a standard one - The process to collaborate with a manufacturer to build a BSC around your needs - Planning for the unique certification and service requirements of a bespoke design Watch now. https://lnkd.in/e-cBB558 #Biosafety #DrugDiscovery #LifeSciences
-
-
Clinical trial investigates oral MRGPRX2 antagonist in urticaria https://lnkd.in/erFmpcmk #ClinicalTrials #Dermatology #DrugDiscovery Evommune
-
-
AstraZeneca and Cancer Research Horizons extend genomics partnership https://lnkd.in/eEmjpzwx #CRISPR #Genomics #DrugDiscovery
-
-
Building advanced cell models for toxicity testing Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are all important for supporting preclinical and clinical pharmaceutical workflows for drug discovery and absorption, distribution, metabolism, excretion, and toxicity (ADMET) testing. In particular, scientists can use primary cells to build advanced 2D and 3D predictive models for liver, skin, vascular, and respiratory toxicities, striving to better understand the pharmacokinetics and metabolism of new compounds. In this webinar, hosted by DDW and supported by Lonza, Kevin Grady and Manisha Nautiyal will review how primary human cells and optimised media systems can be the building blocks for developing the next generation of predictive in vitro ADMET solutions. What you will learn: · About Lonza’s primary cells and media systems for optimised toxicity testing · How to evaluate toxicity in different physiological systems · How to develop advanced, biologically-relevant models using a sophisticated portfolio of products and custom services A Q&A session with the speakers follows the presentations. Thu, Sep 19, 2024 3:00 PM - 4:00 PM BST Register FREE to secure your place. https://lnkd.in/gyZqr-4d Supported by Lonza #CellModels #DrugDiscovery #LifeSciences
-
-
EU orphan designation for pulmonary arterial hypertension drug https://lnkd.in/e582fj6t #DrugDiscovery #OrphanDrugs #Hypertension
-
-
AD | Download the poster to learn more about SpyLock technology: Learn how the SpyLock technology delivers high purity bispecific prototypes to allow for high-throughput screening of hundreds of bispecific antibodies. https://lnkd.in/eR4qt4_4 #BispecificAntibodies #Antibodies #SpyLock Bio-Rad Laboratories
-
-
AstraZeneca comment on precision medicine for kidney disease https://lnkd.in/eGe3sKY4 #KidneyDisease #PrecisionMedicine #DrugDiscovery
-
-
AD | Register now for ELRIG UK’s free-to-attend Drug Discovery 2024 conference https://lnkd.in/eBdMJNhU 🚀 Explore Europe’s premier Drug Discovery event, hosted by ELRIG UK at ExCeL, London on October 2-3. Join industry leaders and innovators for a dynamic experience that fuels your drive for discovery. Featuring a line-up of 100+ speakers, 2000+ delegates, 200 exhibitors, and 260 enlightening posters! 🎯 Immerse yourself in cutting-edge content and key discussions spanning 14 engaging tracks of scientific with insights from 6 fantastic Scientific Content Partners Cell and Gene Therapy Catapult, SiLA Consortium, SLAS (Society for Laboratory Automation and Screening), Royal Society of Chemistry, My Green Lab, Society of Biomolecular Imaging and Informatics. Register now! #DrugDiscovery2024 #ELRIG #DrugDiscovery MSD GSK AstraZeneca SRG
-
-
FDA clears genetically engineered TIL therapy for solid tumour trials https://lnkd.in/eZxSivr4 #LiverTumour #Cancer #Oncology Grit Biotechnology
-